|Bid||34.00 x 1800|
|Ask||35.79 x 900|
|Day's Range||33.53 - 35.42|
|52 Week Range||9.85 - 84.49|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||62.00|
DermTech, Inc. (DMTK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]
LA JOLLA, Calif., July 21, 2021--DermTech, Inc. (NASDAQ: DMTK) ("DermTech"), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today it plans to release its second quarter 2021 financial results after the market closes on Wednesday, August 4, 2021. In conjunction with such release, the Company plans to host a conference call and webcast that day at 1:30 p.m. Pacific time / 4:30 p.m. Eastern time to discuss its financial results and recent highlights.